Selective Targeting GARP–TGF-β1 Increases Antitumor Activity by Remodeling the Immunosuppressive Tumor Microenvironment
Time: 1:00 pm
day: Conference Day Two
Details:
- Developing superior translational models for more accurate representation of patient tumors
- Elucidating the mechanism-of-action by analyzing the tumor microenvironment pre- and post-treatment
- Exploring biomarkers associated with improved results in the combination setting with anti-PD1
